It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Aging leads to a gradual decline in physical activity and disrupted energy homeostasis. The NAD+-dependent SIRT6 deacylase regulates aging and metabolism through mechanisms that largely remain unknown. Here, we show that SIRT6 overexpression leads to a reduction in frailty and lifespan extension in both male and female B6 mice. A combination of physiological assays, in vivo multi-omics analyses and 13C lactate tracing identified an age-dependent decline in glucose homeostasis and hepatic glucose output in wild type mice. In contrast, aged SIRT6-transgenic mice preserve hepatic glucose output and glucose homeostasis through an improvement in the utilization of two major gluconeogenic precursors, lactate and glycerol. To mediate these changes, mechanistically, SIRT6 increases hepatic gluconeogenic gene expression, de novo NAD+ synthesis, and systemically enhances glycerol release from adipose tissue. These findings show that SIRT6 optimizes energy homeostasis in old age to delay frailty and preserve healthy aging.
Aging is associated with increased frailty and disrupted energy homeostasis. Here, the authors show that SIRT6 overexpression extends the lifespan of male and female mice and demonstrate that SIRT6 optimizes energy homeostasis in old age, which delays frailty and preserves healthy aging.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 Bar-Ilan University, The Mina & Everard Goodman Faculty of Life Sciences, Ramat-Gan, Israel (GRID:grid.22098.31) (ISNI:0000 0004 1937 0503)
2 National Institute on Aging, NIH, Translational Gerontology Branch, Intramural Research Program, Baltimore, USA (GRID:grid.419475.a) (ISNI:0000 0000 9372 4913)
3 Technion Integrated Cancer Center, Faculty of Medicine, Technion (Israel Institute of Technology), Haifa, Israel (GRID:grid.6451.6) (ISNI:0000000121102151)
4 Metabolic Syndrome Group–BIOPROMET, Madrid Institute for Advanced Studies-IMDEA Food, CEI UAM + CSIC, Madrid, Spain (GRID:grid.482878.9) (ISNI:0000 0004 0500 5302)
5 Barcelona Institute of Science and Technology (BIST), Catalan Institution for Research and Advanced Studies (ICREA), Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain (GRID:grid.473715.3) (ISNI:0000 0004 6475 7299)